Barclays cuts RGNX target to $12, stays Overweight
Barclays analyst Gena Wang cut their price target on RGNX to $12 on May 15, with the rating unchanged at Overweight.
Gena has made 16 price-target calls on RGNX that AnaChart has tracked. 4 of 16 were touched by the stock’s price at some point after the call.
The rating count on RGNX runs 9 Buy right now. Chardan Capital‘s Daniil Gataulin holds the high end of the range at $52; Morgan Stanley‘s Judah Frommer anchors the low end at $17. The stock’s most recent close was $15.65.

The $12 target is 23% below the stock’s $15.65 close.
FAQ
What is Barclays’s price target on RGNX?
Barclays’s Gena Wang has a $12 target on RGNX, rated Overweight, set May 15, 2026.
How often have Gena Wang’s RGNX price targets been reached?
AnaChart has tracked 16 price-target calls from Gena Wang on RGNX; the stock reached the target in 4 of them (25%).
What is the analyst view on RGNX?
Coverage is split 9 Buy / 0 Hold / 0 Sell, with targets from $17 (Morgan Stanley) to $52 (Chardan Capital).